Virtus ETF Advisers’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-423
| Closed | -$134K | – | 492 |
|
|
2023
Q4 | $134K | Buy |
423
+9
| +2% | +$2.85K | 0.09% | 318 |
|
|
2023
Q3 | $70K | Sell |
414
-39
| -9% | -$6.59K | 0.04% | 385 |
|
|
2023
Q2 | $98.2K | Sell |
453
-44
| -9% | -$9.54K | 0.06% | 393 |
|
|
2023
Q1 | $90.3K | Sell |
497
-188
| -27% | -$34.1K | 0.05% | 365 |
|
|
2022
Q4 | $135K | Sell |
685
-365
| -35% | -$71.7K | 0.07% | 381 |
|
|
2022
Q3 | $236K | Buy |
1,050
+2
| +0.2% | +$450 | 0.09% | 300 |
|
|
2022
Q2 | $133K | Sell |
1,048
-319
| -23% | -$40.5K | 0.05% | 343 |
|
|
2022
Q1 | $173K | Sell |
1,367
-84
| -6% | -$10.6K | 0.08% | 210 |
|
|
2021
Q4 | $190K | Sell |
1,451
-193
| -12% | -$25.3K | 0.07% | 229 |
|
|
2021
Q3 | $201K | Sell |
1,644
-84
| -5% | -$10.3K | 0.09% | 270 |
|
|
2021
Q2 | $197K | Sell |
1,728
-1,458
| -46% | -$166K | 0.08% | 356 |
|
|
2021
Q1 | $383K | Buy |
3,186
+64
| +2% | +$7.69K | 0.16% | 190 |
|
|
2020
Q4 | $317K | Sell |
3,122
-200
| -6% | -$20.3K | 0.13% | 195 |
|
|
2020
Q3 | $257K | Sell |
3,322
-444
| -12% | -$34.3K | 0.13% | 256 |
|
|
2020
Q2 | $420K | Sell |
3,766
-1,750
| -32% | -$195K | 0.2% | 182 |
|
|
2020
Q1 | $397K | Sell |
5,516
-790
| -13% | -$56.9K | 0.16% | 199 |
|
|
2019
Q4 | $475K | Buy |
+6,306
| New | +$475K | 0.08% | 209 |
|